Adults 65 and older may qualify for a clinical research study evaluating an investigational seasonal flu vaccine.
Flu Vaccine Research Study for Adults 65+
Age Range:
65 to 100
Gender:
Male and Female
Location:
Rochester, New York
About the Study
The flu can be more serious for older adults and may sometimes lead to complications or worsening of existing health conditions.
This study is evaluating an investigational mRNA-based seasonal flu vaccine in adults 65 years of age and older. Researchers will compare the investigational vaccine with an age-appropriate, licensed seasonal flu vaccine to learn more about flu prevention, immune response, and vaccine safety.
If you qualify and choose to participate, you will receive one study vaccination and be followed by a dedicated research team during flu season. The study team will monitor your health and ask you to report any flu-like symptoms during the study.
Qualifications
You may be able to join if you:
- Are 65 years of age or older
- Are willing to receive a study vaccination
- Are able to attend study visits or follow-up contacts
- Are willing to report flu-like symptoms during the study
- Are able to follow study instructions, including use of a study diary if needed
Additional eligibility criteria will be reviewed by the study team.
FEATURED STUDIES
An upcoming clinical research study is evaluating an investigational treatment designed to help prevent the flu in adults who may […]
An upcoming clinical research study is evaluating an investigational vaccine designed to help prevent illness caused by norovirus in adults […]
An upcoming clinical research study is evaluating an investigational long-acting approach designed to help prevent influenza. Join our interest list […]
Adults 65 and older may qualify for a clinical research study evaluating an investigational seasonal flu vaccine.
This clinical trial will help us learn if receiving another dose of the RSV vaccine is safe and can help […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]